Clicky

Seelos Therapeutics, Inc.(SEEL)

Description: Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.


Keywords: Biopharmaceutical Disorders Movement Disorders Orphan Disease

Home Page: seelostherapeutics.com

SEEL Technical Analysis

300 Park Avenue
New York, NY 10022
United States
Phone: 646 293 2100


Officers

Name Title
Dr. Raj Mehra J.D., Ph.D. Founder, Chairman, CEO & Pres
Mr. Michael J. Golembiewski Chief Financial Officer
Ms. Kimberly Farrand Sr. Director of Clinical Devel. & Operations
Mr. Anthony Marciano Chief Communications Officer
Gopal Krishna Ph.D. Head of Manufacturing & Technical Operations
Tim Whitaker M.D. Chief Medical Officer
Ms. Karen Fusaro Sr. VP & Head of Clinical Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 15.098
Price-to-Sales TTM: 421.8987
IPO Date: 1999-04-19
Fiscal Year End: December
Full Time Employees: 16
Back to stocks